Biodesix, Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was USD 13.49 million compared to USD 11.11 million a year ago. Net loss was USD 10.95 million compared to USD 13.7 million a year ago. Basic loss per share from continuing operations was USD 0.14 compared to USD 0.34 a year ago.
For the nine months, sales was USD 34.42 million compared to USD 28.61 million a year ago. Net loss was USD 43.01 million compared to USD 45.11 million a year ago. Basic loss per share from continuing operations was USD 0.55 compared to USD 1.22 a year ago.